These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 26482726
1. Assessment of ixekizumab, an interleukin-17A monoclonal antibody, for potential effects on reproduction and development, including immune system function, in cynomolgus monkeys. Clarke DO, Hilbish KG, Waters DG, Newcomb DL, Chellman GJ. Reprod Toxicol; 2015 Dec; 58():160-73. PubMed ID: 26482726 [Abstract] [Full Text] [Related]
3. Effects of SA237, a humanized anti-interleukin-6 receptor monoclonal antibody, on pre- and postnatal development in cynomolgus monkey. Katagiri R, Ishihara-Hattori K, Frings W, Amano J, Fuchs A, Chiba S. Birth Defects Res; 2017 Jul 03; 109(11):843-856. PubMed ID: 28504465 [Abstract] [Full Text] [Related]
4. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation. Martin PL, Sachs C, Imai N, Tsusaki H, Oneda S, Jiao Q, Treacy G. Birth Defects Res B Dev Reprod Toxicol; 2010 Oct 03; 89(5):351-63. PubMed ID: 20540088 [Abstract] [Full Text] [Related]
7. An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody. Breslin WJ, Hilbish KG, Martin JA, Halstead CA, Newcomb DL, Chellman GJ. Birth Defects Res B Dev Reprod Toxicol; 2015 Jun 03; 104(3):100-16. PubMed ID: 26195230 [Abstract] [Full Text] [Related]
10. Fertility and developmental toxicity assessment in rats and rabbits with LY500307, a selective estrogen receptor beta (ERβ) agonist. Hilbish KG, Breslin WJ, Johnson JT, Sloter ED. Birth Defects Res B Dev Reprod Toxicol; 2013 Oct 03; 98(5):400-15. PubMed ID: 24323950 [Abstract] [Full Text] [Related]
12. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period. Boyce RW, Varela A, Chouinard L, Bussiere JL, Chellman GJ, Ominsky MS, Pyrah IT. Bone; 2014 Jul 03; 64():314-25. PubMed ID: 24727159 [Abstract] [Full Text] [Related]
16. Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an alpha4 integrin inhibitor. Wehner NG, Shopp G, Osterburg I, Fuchs A, Buse E, Clarke J. Birth Defects Res B Dev Reprod Toxicol; 2009 Apr 03; 86(2):144-56. PubMed ID: 19283860 [Abstract] [Full Text] [Related]
17. Farletuzumab, a monoclonal antibody directed against folate receptor alpha, shows no evidence of teratogenicity in cynomolgus monkeys. Moriyama T, Kakiuchi D, Grasso L, Hutto DL, Fernando D, Schweizer C. Reprod Toxicol; 2018 Aug 03; 79():89-95. PubMed ID: 29928988 [Abstract] [Full Text] [Related]
18. Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague-Dawley rats. Wise LD, Wolf JJ, Kaplanski CV, Pauley CJ, Ledwith BJ. Birth Defects Res B Dev Reprod Toxicol; 2008 Dec 03; 83(6):561-72. PubMed ID: 19025783 [Abstract] [Full Text] [Related]
19. TGF-β1 monoclonal antibody: Assessment of embryo-fetal toxicity in rats and rabbits. Hilbish KG, Martin JA, Stauber AJ, Edwards TL, Breslin WJ. Birth Defects Res B Dev Reprod Toxicol; 2016 Aug 03; 107(4-5):174-184. PubMed ID: 27519584 [Abstract] [Full Text] [Related]
20. A comparison of effects on reproduction and neonatal development in cynomolgus monkeys given human soluble IL-4R and mice given murine soluble IL-4R. Carlock LL, Cowan LA, Oneda S, Hoberman A, Wang DD, Hanna R, Bussiere JL. Regul Toxicol Pharmacol; 2009 Apr 03; 53(3):226-34. PubMed ID: 19217923 [Abstract] [Full Text] [Related] Page: [Next] [New Search]